Bharat Biotech confirms deal with Brazil for 20 million doses of Covaxin
Bharat Biotech International Limited on Friday announced that the company has signed an agreement with Brazil for the supply of 20 million doses of its covid-19 vaccine COVAXIN.
“The company is delighted to partner with Brazil in its battle against Covid-19 and aid its immunization program against the virus. It has signed an agreement for delivery of COVAXIN during Q2 (April to June) and Q3 (July to September) (of) 2021,” the company said in a statement.
It added, “There is a strong interest in Covaxin from many countries around the world, and the company is fully committed to ensuring supplies promptly and efficiently.”
In January, India dispatched two million doses of Covishield vaccines to Brazil. Covishield has been developed by AstraZeneca and Oxford University and is being manufactured by Serum Institute of India.
Brazil President Jair Bolsonaro thanked Prime Minister Narendra Modi by saying “dhanyavaad” for supplying the “sanjeevni booti” (the vaccine) against the coronavirus to the South American country, which has reported the second-highest death toll from the Covid-19 disease in the world.